This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday
Apogee Therapeutics, Inc. +1.82%
Arcturus Therapeutics +0.11%
Carnival Corporation +6.99%
Tandem Diabetes Care, Inc. +2.59%
Union Pacific Corporation +0.03%
Apogee Therapeutics, Inc. APGE | 92.20 | +1.82% |
Arcturus Therapeutics ARCT | 8.85 | +0.11% |
Carnival Corporation CCL | 29.22 | +6.99% |
Tandem Diabetes Care, Inc. TNDM | 20.61 | +2.59% |
Union Pacific Corporation UNP | 251.14 | +0.03% |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Morgan Stanley analyst Jamie Rollo upgraded Carnival Corp (NYSE:CCL) from Equal-Weight to Overweight and cut the price target from $33 to $31. Carnival shares closed at $24.16 on Wednesday. See how other analysts view this stock.
- Truist Securities analyst Richard Newitter upgraded Tandem Diabetes Care Inc (NASDAQ:TNDM) from Hold to Buy and raised the price target from $27 to $35. Tandem Diabetes Care shares closed at $23.85 on Wednesday. See how other analysts view this stock.
- Evercore ISI Group analyst Jonathan Chappell upgraded Union Pacific Corp (NYSE:UNP) from In-Line to Outperform and raised the price target from $260 to $262. Union Pacific shares closed at $236.57 on Wednesday. See how other analysts view this stock.
Considering buying UNP stock? Here’s what analysts think:
Photo via Shutterstock
